Similar articles

• Cyclin D and oncogenesis.

  Motokura T, Arnold A. Motokura T, et al. Curr Opin Genet Dev. 1993 Feb;3(1):5-10. doi: 10.1016/s0959-437x(05)80334-x. Curr Opin Genet Dev. 1993. PMID: 8453274 Review.
• Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.

  Uchimaru K, Endo K, Fujinuma H, Zukerberg L, Arnold A, Motokura T. Uchimaru K, et al. Jpn J Cancer Res. 1996 May;87(5):459-65. doi: 10.1111/j.1349-7006.1996.tb00246.x. Jpn J Cancer Res. 1996. PMID: 8641982 Free PMC article.
• Cyclin D1 as the putative bcl-1 oncogene.

  Harris AW, Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Adams JM. Harris AW, et al. Curr Top Microbiol Immunol. 1995;194:347-53. doi: 10.1007/978-3-642-79275-5_40. Curr Top Microbiol Immunol. 1995. PMID: 7895508 Review. No abstract available.
• Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.

  Lovec H, Sewing A, Lucibello FC, Müller R, Möröy T. Lovec H, et al. Oncogene. 1994 Jan;9(1):323-6. Oncogene. 1994. PMID: 8302597
• How cells cycle toward cancer.

  Marx J. Marx J. Science. 1994 Jan 21;263(5145):319-21. doi: 10.1126/science.8278804. Science. 1994. PMID: 8278804 No abstract available.